PHK
NGNE icon

Point72 Hong Kong’s Neurogene NGNE Stock Holding History

Point72 Hong Kong’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-49
Closed -$2K – 2254
2022
Q1 		$2K Buy
49
+39
+390% +$2.27K ﹤0.01% 1733
2021
Q4 		$1K Sell
10
-57
-85% -$6.94K ﹤0.01% 1804
2021
Q3 		$10K Sell
67
-13
-16% -$1.99K ﹤0.01% 1798
2021
Q2 		$15K Buy
+80
New +$17.7K ﹤0.01% 1678

Other funds holding NGNE

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Hong Kong's NGNE Position: Q2 2022 in Review

Point72 Hong Kong sold out of Neurogene (NGNE) in Q2 2022, closing a stake of 49 shares — an estimated $2K sold.

Point72 Hong Kong first reported a position in NGNE in Q2 2021 and held it in 4 quarters. The position peaked at $15K in Q2 2021. 63 funds tracked by Wall St. Rank hold NGNE as of Q2 2022.

  • Point72 Hong Kong reported no remaining Neurogene position as of Q2 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 49 Neurogene shares in Q2 2022, an estimated $2K.
  • Point72 Hong Kong first reported a position in Neurogene in Q2 2021 and held it in 4 quarters.
  • Point72 Hong Kong's Neurogene position peaked at $15K in Q2 2021.
  • 63 funds tracked by Wall St. Rank held Neurogene as of Q2 2022.

Based on Point72 Hong Kong's 13F filing for Q2 2022, filed 15 Aug 2022.